tüüp : |
ajaleht |
interneti link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=3891 |
|
uurimisrühmad : |
Boston - Massachusetts Eye and Ear Infirmary, Harvard Medical School |
Autor : |
Robert M.C, Spurr-Michaud S, Frenette M, Young D, Gipson Ilene K, Dohlman Claes H. |
pealkiri : |
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation. |
publikatsioon : |
Int J Pharm Compound ;18, 5: 418-426. 2014 |
|
Tõendite tase : |
|
füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
|
ingredientide nimekiri
Infliximab
|
|
|
|
|
100 mg Remicade ® |
naatriumkarboksümetüültselluloos |
50 mg |
boorhape |
|
CaCl2 |
|
MgCl2 |
|
KCl |
|
süstevesi |
>> 10 ml |
|
-20°C |
|
45 |
|
|
|
|
|
|
100 mg Remicade ® |
naatriumkarboksümetüültselluloos |
50 mg |
boorhape |
|
CaCl2 |
|
MgCl2 |
|
KCl |
|
süstevesi |
>> 10 ml |
|
4°C |
|
45 |
|
|
|
|
|